ÐÓ°ÉÔ­´´

Daye, based in London, operates as a biotech and health tech company focusing on innovative products and services for vaginal health. Targeting a niche market within women's health, the company offers a mix of over-the-counter products and specialized treatments for poorly managed gynecological conditions. Its direct-to-consumer model emphasizes accessibility and customer engagement, fostering brand loyalty and repeat business. Supported by significant investments from notable venture capital firms, Daye has the financial means to scale operations, invest in R&D, and enhance its ecommerce platform. Its commitment to innovation and market-specific solutions sets it apart, potentially making it a leader in women's health.